CMS discusses VBP's effects on Medicaid best price

In new guidance discussing the effects of future value-based pricing (VBP) arrangements on Medicaid best prices, CMS encouraged states and manufacturers to negotiate CMS-approved supplemental rebates that would be excluded from Medicaid best price.

Last

Read the full 342 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE